Items where authors include "Hanby, A"

Article

Bundred, N, Porta, N, Brunt, AM et al. (20 more authors) (2022) Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clinical Cancer Research. ISSN 1078-0432

Kather, JN, Heij, LR, Grabsch, H orcid.org/0000-0001-9520-6228 et al. (25 more authors) (2020) Pan-cancer image-based detection of clinically actionable genetic alterations. Nature Cancer, 1 (8). pp. 789-799. ISSN 2662-1347

Smittenaar, P, Walker, AK, McGill, S et al. (13 more authors) (2018) Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer. British Journal of Cancer, 119 (2). pp. 220-229. ISSN 0007-0920

Williams, BJ, Hanby, A orcid.org/0000-0001-7966-1570, Millican-Slater, R et al. (3 more authors) (2018) Digital Pathology for the Primary Diagnosis of Breast Histopathological Specimens: An Innovative Validation and Concordance Study. Histopathology, 72 (4). pp. 662-671. ISSN 0309-0167

Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Copson, ER, Maishman, TC, Tapper, WJ et al. (21 more authors) (2018) Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. The Lancet Oncology, 19 (2). pp. 169-180. ISSN 1470-2045

Garcia-Dios, DA, Levi, D, Shah, V et al. (5 more authors) (2018) MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours. British Journal of Cancer, 118. pp. 277-284. ISSN 0007-0920

Coleman, R, Hall, A, Albanell, J et al. (10 more authors) (2017) Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial. The Lancet Oncology, 18 (11). pp. 1543-1552. ISSN 1470-2045

Avgustinova, A, Iravani, M, Robertson, D et al. (8 more authors) (2016) Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness. Nature Communications, 7. 10305. ISSN 2041-1723

Booth, M, Treanor, D, Roberts, N et al. (3 more authors) (2015) Three dimensional reconstruction of ductal carcinoma in situ using virtual slides. Histopathology, 66 (7). 966 - 973. ISSN 0309-0167

Proceedings Paper

Humphries, MP, Suleman, C, Hanby, A et al. (1 more author) (2016) A comparative study of male versus female breast cancer identifies overexpression of eiF signalling pathways in male breast cancer providing opportunities for a therapeutic window. In: Breast Cancer Research and Treatment. UK Breast Cancer Research Symposium 2016, 22-23 Jul 2016, London, UK. Springer Verlag , p. 188.